Skip to Main Content

Paper Details

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial.
Ann Oncol
37
2021
AR, HSPC, MVA, PATIENTS, PC, RNA signatures, androgen, androgen receptor, basal subtype, castration-resistant, docetaxel, mHSPC, metastatic hormone-sensitive prostate cancer, patients, prostate tumor
Author NameAffiliation
Felix Y FengHelen Diller Family Comprehensive Cancer Center, University of California San Francisco
Robert B DenSidney Kimmel Medical College at Thomas Jefferson University
Gerhardt AttardUniversity College London Cancer Institute
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenDana-Farber Cancer Institute
Phuoc T TranSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ryan Dittamore
Elai Davicioni
Michael A CarducciSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • 1 - 9

Datasets

Release 1.2